Despite a revenue dip, Harvard Bioscience Inc (HBIO) focuses on new product launches and cost-saving measures to drive future growth.
New products complement an already extensive range of products enabling fundamental advancements in neuroscience researchHOLLISTON, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) 2024 Annual Meeting being held October 5 - 9 in Chicago. Cutting-edge innovations on display include the revolutionary new Mesh MEA™ microelectrode array system, the SoHo™ imp
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...